ProMIS Gross Profit vs Other Operating Expenses Analysis

PMN Stock  USD 0.96  0.05  4.95%   
ProMIS Neurosciences financial indicator trend analysis is much more than just breaking down ProMIS Neurosciences prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether ProMIS Neurosciences is a good investment. Please check the relationship between ProMIS Neurosciences Gross Profit and its Other Operating Expenses accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProMIS Neurosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
To learn how to invest in ProMIS Stock, please use our How to Invest in ProMIS Neurosciences guide.

Gross Profit vs Other Operating Expenses

Gross Profit vs Other Operating Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of ProMIS Neurosciences Gross Profit account and Other Operating Expenses. At this time, the significance of the direction appears to have pay attention.
The correlation between ProMIS Neurosciences' Gross Profit and Other Operating Expenses is -0.93. Overlapping area represents the amount of variation of Gross Profit that can explain the historical movement of Other Operating Expenses in the same time period over historical financial statements of ProMIS Neurosciences, assuming nothing else is changed. The correlation between historical values of ProMIS Neurosciences' Gross Profit and Other Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Gross Profit of ProMIS Neurosciences are associated (or correlated) with its Other Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Operating Expenses has no effect on the direction of Gross Profit i.e., ProMIS Neurosciences' Gross Profit and Other Operating Expenses go up and down completely randomly.

Correlation Coefficient

-0.93
Relationship DirectionNegative 
Relationship StrengthSignificant

Gross Profit

Gross profit is a required income statement account that reflects total revenue of ProMIS Neurosciences minus its cost of goods sold. It is profit before ProMIS Neurosciences operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of ProMIS Neurosciences. It is also known as ProMIS Neurosciences overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most indicators from ProMIS Neurosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ProMIS Neurosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProMIS Neurosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
To learn how to invest in ProMIS Stock, please use our How to Invest in ProMIS Neurosciences guide.At this time, ProMIS Neurosciences' Selling General Administrative is very stable compared to the past year. As of the 12th of December 2024, Issuance Of Capital Stock is likely to grow to about 24.4 M, while Sales General And Administrative To Revenue is likely to drop 348.08.
 2021 2023 2024 (projected)
Cost Of Revenue5.9M10.4M11.3M
Interest Income4.7K5.4K5.7K

ProMIS Neurosciences fundamental ratios Correlations

0.70.81-0.21-0.98-0.740.690.99-0.71.00.40.8-0.030.620.840.90.981.0-0.660.560.040.510.17-0.640.620.69
0.70.34-0.22-0.78-0.890.950.69-0.620.680.480.94-0.17-0.060.930.920.760.7-0.550.810.180.530.13-0.840.620.88
0.810.34-0.07-0.73-0.280.470.76-0.540.820.310.470.320.550.510.520.680.81-0.510.08-0.310.080.17-0.520.340.52
-0.21-0.22-0.070.290.29-0.24-0.280.64-0.2-0.09-0.240.54-0.13-0.39-0.21-0.24-0.21-0.23-0.03-0.53-0.260.40.19-0.08-0.21
-0.98-0.78-0.730.290.83-0.77-0.990.71-0.98-0.39-0.880.18-0.54-0.91-0.93-0.99-0.980.61-0.6-0.19-0.62-0.110.69-0.67-0.78
-0.74-0.89-0.280.290.83-0.79-0.780.62-0.72-0.33-0.960.45-0.21-0.92-0.91-0.84-0.740.58-0.84-0.46-0.840.030.66-0.82-0.79
0.690.950.47-0.24-0.77-0.790.69-0.580.680.480.9-0.13-0.10.890.850.720.7-0.430.60.140.390.13-0.930.510.93
0.990.690.76-0.28-0.99-0.780.69-0.680.990.360.82-0.180.640.860.890.990.99-0.590.540.180.590.11-0.640.640.7
-0.7-0.62-0.540.640.710.62-0.58-0.68-0.69-0.37-0.670.03-0.28-0.77-0.67-0.67-0.70.57-0.55-0.03-0.40.180.49-0.53-0.57
1.00.680.82-0.2-0.98-0.720.680.99-0.690.390.79-0.020.640.830.880.971.0-0.660.530.030.50.17-0.630.60.68
0.40.480.31-0.09-0.39-0.330.480.36-0.370.390.420.14-0.010.40.450.380.4-0.270.36-0.140.010.17-0.510.220.34
0.80.940.47-0.24-0.88-0.960.90.82-0.670.790.42-0.280.150.960.930.860.8-0.630.780.280.690.02-0.820.790.9
-0.03-0.170.320.540.180.45-0.13-0.180.03-0.020.14-0.28-0.1-0.26-0.17-0.19-0.03-0.35-0.11-1.0-0.640.390.1-0.28-0.16
0.62-0.060.55-0.13-0.54-0.21-0.10.64-0.280.64-0.010.15-0.10.210.320.590.62-0.290.060.110.360.060.090.26-0.03
0.840.930.51-0.39-0.91-0.920.890.86-0.770.830.40.96-0.260.210.950.890.85-0.590.770.260.640.08-0.790.740.85
0.90.920.52-0.21-0.93-0.910.850.89-0.670.880.450.93-0.170.320.950.940.9-0.640.790.180.610.16-0.740.660.79
0.980.760.68-0.24-0.99-0.840.720.99-0.670.970.380.86-0.190.590.890.940.98-0.630.640.20.630.15-0.650.660.71
1.00.70.81-0.21-0.98-0.740.70.99-0.71.00.40.8-0.030.620.850.90.98-0.660.560.040.510.17-0.640.620.69
-0.66-0.55-0.51-0.230.610.58-0.43-0.590.57-0.66-0.27-0.63-0.35-0.29-0.59-0.64-0.63-0.66-0.740.35-0.46-0.110.31-0.69-0.51
0.560.810.08-0.03-0.6-0.840.60.54-0.550.530.360.78-0.110.060.770.790.640.56-0.740.110.650.14-0.450.760.55
0.040.18-0.31-0.53-0.19-0.460.140.18-0.030.03-0.140.28-1.00.110.260.180.20.040.350.110.64-0.38-0.10.290.17
0.510.530.08-0.26-0.62-0.840.390.59-0.40.50.010.69-0.640.360.640.610.630.51-0.460.650.64-0.2-0.210.790.54
0.170.130.170.4-0.110.030.130.110.180.170.170.020.390.060.080.160.150.17-0.110.14-0.38-0.2-0.120.020.08
-0.64-0.84-0.520.190.690.66-0.93-0.640.49-0.63-0.51-0.820.10.09-0.79-0.74-0.65-0.640.31-0.45-0.1-0.21-0.12-0.45-0.81
0.620.620.34-0.08-0.67-0.820.510.64-0.530.60.220.79-0.280.260.740.660.660.62-0.690.760.290.790.02-0.450.6
0.690.880.52-0.21-0.78-0.790.930.7-0.570.680.340.9-0.16-0.030.850.790.710.69-0.510.550.170.540.08-0.810.6
Click cells to compare fundamentals

ProMIS Neurosciences Account Relationship Matchups

ProMIS Neurosciences fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets2.1M1.4M22.4M9.4M18.0M18.9M
Total Current Liabilities1.7M2.4M1.2M8.7M12.4M13.0M
Total Stockholder Equity398.1K(1.0M)7.2M(1.8M)5.0M5.2M
Property Plant And Equipment Net0.099.6K5.9K434.62391.16371.6
Net Debt(1.7M)(1.0M)(16.5M)(8.0M)(16.7M)(15.9M)
Retained Earnings(65.6M)(71.2M)(78.6M)(108.7M)(123.8M)(117.6M)
Accounts Payable465.0K437.5K409.0K3.0M10.4M10.9M
Cash1.7M1.0M21.4M8.0M16.7M17.5M
Non Current Assets Total48.3K144.2K40.8K28.6K25.8K24.5K
Cash And Short Term Investments1.7M1.1M21.5M8.0M16.8M17.6M
Net Receivables56.8K31.0K48.7K71.6K64.5K110.2K
Common Stock Shares Outstanding4.3M4.8M5.8M7.5M12.3M12.9M
Short Term Investments41.8K76.7K50.7K59.5K61.6K58.6K
Liabilities And Stockholders Equity2.1M1.4M22.4M6.9M17.4M18.2M
Non Current Liabilities Total1.1M437.5K14.1M1.9M683.9K649.7K
Inventory(56.8K)(31.0K)(48.7K)(71.6K)(64.5K)(61.2K)
Other Current Assets321.8K135.0K688.6K925.1K1.3M1.4M
Other Stockholder Equity8.1M28.9M85.8M107.0M129.3M135.8M
Total Liab1.7M2.4M15.3M8.7M13.1M13.7M
Total Current Assets2.0M1.2M22.4M9.3M18.0M18.9M
Accumulated Other Comprehensive Income8.9M9.1M(237.6K)(264.5K)(491.8K)(467.2K)
Intangible Assets48.3K41.6K34.9K28.2K25.4K43.6K
Other Current Liab1.2M1.4M765.9K3.4M2.0M2.1M
Common Stock45.2M49.0M52.7M56.5M65.0M38.3M
Good Will(12.6K)(14.6K)(11.3K)(9.0K)(8.1K)(8.5K)
Net Tangible Assets349.8K(1.1M)7.4M(1.4M)(1.6M)(1.5M)
Net Invested Capital304.8K(796.7K)9.7M(1.3M)(1.5M)(1.5M)
Net Working Capital267.8K(909.8K)16.7M490.4K564.0K535.8K

Pair Trading with ProMIS Neurosciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ProMIS Neurosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProMIS Neurosciences will appreciate offsetting losses from the drop in the long position's value.

Moving together with ProMIS Stock

  0.71VALN Valneva SE ADRPairCorr
  0.73ERNA Eterna TherapeuticsPairCorr

Moving against ProMIS Stock

  0.81BMY Bristol Myers SquibbPairCorr
  0.72GILD Gilead SciencesPairCorr
  0.69ESPR Esperion TherapeuticsPairCorr
  0.47DNA Ginkgo Bioworks HoldingsPairCorr
  0.46FLGC Flora Growth CorpPairCorr
The ability to find closely correlated positions to ProMIS Neurosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ProMIS Neurosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ProMIS Neurosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ProMIS Neurosciences to buy it.
The correlation of ProMIS Neurosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ProMIS Neurosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ProMIS Neurosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ProMIS Neurosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether ProMIS Neurosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ProMIS Neurosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Promis Neurosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Promis Neurosciences Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProMIS Neurosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
To learn how to invest in ProMIS Stock, please use our How to Invest in ProMIS Neurosciences guide.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProMIS Neurosciences. If investors know ProMIS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProMIS Neurosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.04
Revenue Per Share
0.001
Return On Assets
(4.81)
Return On Equity
(10.99)
The market value of ProMIS Neurosciences is measured differently than its book value, which is the value of ProMIS that is recorded on the company's balance sheet. Investors also form their own opinion of ProMIS Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is ProMIS Neurosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProMIS Neurosciences' market value can be influenced by many factors that don't directly affect ProMIS Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProMIS Neurosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if ProMIS Neurosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProMIS Neurosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.